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The phthalocyanine analogue containing nonperipheral long alkyl-substituted benzenoid rings and pyridine rings, zinc bis(1,4-
didecylbenzo)-bis(2,3-pyrido) porphyrazine, was synthesized. Zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine reacted
with dimethyl sulfate and monochloroacetic acid to produce their quaternized products and diethyl sulfate to produce the sulfo-
substituted products. All quaternized and sulfo-substituted showed amphiphilic character. Identical peaks in cyclic voltammo-
grams appeared for these products before and after quaternization. During the evaluation of zinc bis(1,4-didecylbenzo)-bis(2,3-
pyrido) porphyrazine for its photodynamic therapy of cancer (PDT) eﬃcacy by cancer cell culture, the light exposed dimethyl
sulfate quaternized zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazines in IU-002 cells produce cell disruption that can be
detected as a decrease in ﬂuorescence.
Copyright © 2008 Keiichi Sakamoto et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Phthalocyanine derivatives have attracted attention as func-
tional chromophores for applications, especially organic
charge carriers in photocopiers, as laser light absorbers in
data storage systems, as photoconductors in photovoltaic
cells, and in electrochromic displays [1–3]. Moreover, ph-
thalocyanine derivatives can be utilized as sensitizers in pho-
todynamic therapy of cancer (PDT).
Sensitizers for PDT require high photostability, high se-
lectivity to tumors, no dark cytotoxity, strong absorption in
the region between 600 and 800nm where penetration of
tissue is good, a long triplet lifetime, and satisfactory pho-
tosensitization of singlet oxygen. Phthalocyanine derivatives
are known to satisfy the aforementioned conditions [3–8].
We previously synthesized the nonperipherally substi-
tuted phthalocyanine derivatives, zinc alkylbenzopyridopor-
phyrazines, which possessed didecylbenzenoid and pyridi-
noid moieties in the molecule and described regio iso-
mer separation of one of the alkylbenzopyridoporphyrazines
[9]. We reported a fundamental study on PDT by mea-
suring for the triplet state lifetime of the alkylbenzopyri-
doporphyrazins and regio isomers [10, 11]. As alkylben-
zopyridoporphyrazine exhibited solubility in organic sol-
vents and was expected to have a higher tumor aﬃnity, qua-
ternation of the pyridine nitrogen in the alkylbenzopyri-
doporphyrazine was done to give solubility in anaqueous
media, and to have bioavailability and in vivo distribution
[12]. Then, Nyokong et al. reported that phthalocyanine
analogues, tetra-2, 3-pyridoporphyrazine and its quater-
nizedcompoundshaveexcellentpropertiescomparedtozinc
phthalocyanine-type photosensitizer [13]. The amphiphilic
phthalocyanine derivatives were concluded the best com-
pound for a new generation of photosensitizers for PDT2 Metal-Based Drugs
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Figure 1: Synthetic pathway of zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine.
[12]. In our previous papers [9–12], the reported zinc
bis(1,4-didecylbenzo)-bis(3,4-pyrido) porphyrazine and its
regio isomers were prepared by 1 : 1 mixture of 3,6-
didecylphthalonitrile and 3,4-pyridine dicarbonitrile.
In the present study, another type, novel nonperiph-
eral, substituted phthalocyanine derivative, zinc bis(1,4-
didecylbenzo)-bis(2,3-pyrido) porphyrazine was synthe-
sized.
In the case of related compounds, 2,3-pyridoporphyrazi-
nes are known to have not only longer wavelength but
stronger absorption intensity than corresponding phthalo-
cyanines and 3,4-pyridoporphyrazines [14]. In accordance
with [14], it is expected that zinc bis(1,4-didecylbenzo)-
bis(2,3-pyrido) porphyrazine and its quaternation com-
pounds have stronger absorption intensities than that
of zinc bis(1,4-didecylbenzo)-bis(3,4-pyrido) porphyrazines
reported before [9–12].Therefore,thenovelcompound,zinc
bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine and its
quaternation compounds are expected to be excellent pho-
tosensitizer for PDT.
2. RESULTS AND DISCUSSION
2.1. Synthesisandquaternizationof
phthalocyaninederivative
The synthetic procedure used to prepare the novel
nonperipheral-substituted phthalocyanine derivative,
zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazines,
was the same as that used for the preparation of zinc
bis(1,4-didecylbenzo)-bis(3,4-pyrido) porphyrazine [9–12].
Zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine
was synthesized in 80% yield using equimolar amounts of
3,6-didecylphthalodinitrile and 2,3-pyridine carbonitrile in
the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU)
as basic catalyst (see Figure 1). The target compound, zinc
bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine, and its
intermediates were studied using Fourier transformation in-
frared (IR), proton nuclear magnetic resonance (1H-NMR),
ultraviolet-visible (UV-Vis) spectroscopy, and elemental
analysis. The analytical data of the compound were in good
agreement with the proposed structure.
The synthesized zinc bis(1,4-didecylbenzo)-bis(2,3-
pyrido) porphyrazine was anticipated to be a mixture
of products, with diﬀerent numbers of pyridine rings in
the molecule. However, the target compound comprised
only the proposed constituent as conﬁrmed by thin layer
chromatography (TLC). As the target compound had
been puriﬁed by TLC using benzene as eluent, only one
blue-colored constituent was obtained. It is thought that
the desired compound was obtained in accordance with
the mole ratio of the raw materials used. The same phe-
nomenon has been observed in the case of synthesis of zinc
bis(1,4-didecylbenzo)-bis(3,4-pyrido) porphyrazine [9–12].
Zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyra-
zine has two alkylbenzenoid and two pyridinoid rings in dif-
ferentlocations; thus, it hasﬁveregio isomers, three of which
have rings adjacent to the pyridinoido rings while the other
two have opposed pyridinoid rings. Although we previously
reported the separation of regio isomers in alkylbenzopyri-
doporphyrazine [9–12], no attempt was made in this work
to isolate the isomers of zinc bis(1,4-didecylbenzo)-bis(2,3-
pyrido) porphyrazine. Of course, the obtained blue-colored
constituent will be further separated into ﬁve regio isomers
by using toluene-pyridine 7 : 3 eluent in accordance with [9–
12].
The zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphy-
razine reacted with quaternizing agents such as
monochloroacetic acid (MCAA), diethyl sulfate (DES),
and dimethyl sulfate (DMS) in N,N-dimethylformamide
(DMF) as a solvent at 140◦Cf o r2h o u r s .
The respective products obtained were greenish-blue-
colored powders of which the yields were 24, 21, and 25%
for MCAA, DES, and DMS, respectively (see Figure 3). Zinc
bis(1,4-didecylbenzo)-bis(2,3-pyrido)porphyrazinewasdis-
solved in toluene, chloroform, pyridine, and methanol but
not in water. After reacting with quaternizing agents, the
products were also soluble in water.Keiichi Sakamoto et al. 3
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Figure 2: Typical structures of quaternized zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazines.
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Figure 3: CVs of zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine.
In the cases of MCAA and DMS, analysis revealed that
the structures of the products were in good agreement with
thosehavingN-CH2COOHandN-CH3 groups,respectively.
Whereas when DES was used as a quaternizing agent, no N-
CH2CH3 singlet peak was present in the 1H-NMR spectrum,
S=O stretching in the IR spectrum was observed. Therefore,
sulfonation but not quaternization was achieved [12, 15].
After reaction with the quaternizing agents, all com-
pounds possessed amphiphilic properties.
2.2. Spectroscopicandelectrochemicalproperties
The UV-Vis spectrum of zinc bis(1,4-didecylbenzo)-bis(2,3-
pyrido) porphyrazines around 700nm is characteristic4 Metal-Based Drugs
Table 1: UV-Vis and ﬂuorescence spectral data of quaternized zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine.
Compound Q-band Fluorescence
λmax pyridine/nm λmax water/nm Fmax pyridine/nm Fmax water/nm
1 687 — 694 —
2665 — — —
2
1679, 650 1687, 647 692 688
1,2677, 2620
3
1693, 658, 628, 597 708, 1687, 652 698 691
2673, 2645, 2605
4 746, 1673, 649, 606 723, 1676, 646 683 688
2738, 1,2668, 2641, 2600
1 Main peak.
2In toluene.
Table 2: Potentials of quaternized zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine in DMF with tetrabutylammonium perchlo-
rate.Potentials of reversible wave are midpoint potential of anodic to cathodic peaks for each couple.
Potential (V versus Ag/AgCl)
Compound Reduction (E pc) Oxidation (E pa)
1 –0.94∗ –0.62∗ –0.29∗ –0.03∗ 0.32∗ 0.48∗ 0.97∗
Δ E ∗∗
2 –0.75∗ –0.52∗ –0.12∗ 0.96∗ 1.28∗
Δ E ∗∗
3 –0.83 –0.51∗ –0.05∗ 0.25∗ 1.05∗
Δ E ∗∗ 0.14
4 –1.15∗ –0.77 –0.14∗ –0.05∗ 0.50∗
Δ E ∗∗ 0.11
∗ Irreversible peak.
∗∗The anodic peak to cathodic peak separation for reversible couple.
ofphthalocyanine analogues, with the Q band attributable
to the diﬀerence between the highest occupied molecular
orbital (HOMO) energy level and the lowest unoccupied
molecular orbital (LUMO) energy, that is, the π-π∗ transi-
tion of the phthalocyanine ring.
The quarternized derivatives of zinc bis(1,4-didecyl-
benzo)-bis(2,3-pyrido) porphyrazines showed strongest ab-
sorption at 676, 687, and 687nm in water after reaction with
DMS,DES,andMCAA,respectively(Table 1);theseQbands
were bathochromic compared to the nonquaternized parent
compound. As the UV-Vis spectra of the quaternized com-
pounds in water showed very broad peaks, the amphiphilic
compounds had excellent molecular association tendency.
Zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyra-
zine and its quaternized compounds ﬂuoresced on expo-
sure to ultraviolet light. Although ﬂuorescence spectra gen-
erally were known to be mirror images of UV-Vis spectra
at the longer wavelengths, the Q bands nearly overlapped
with the wavelengths at which ﬂuorescence occurs in the
caseofzincbis(1,4-didecylbenzo)-bis(2,3-pyrido)porphyra-
zine and its quaternized compounds, thus, the diﬀerences
between λmax of UV-Vis and the Fmax of ﬂuorescence spec-
tra, called the Storkes shift, were very small between 10 to
20nm. These observations are similar to that seen with the
phthalocyanines zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido)
porphyrazine and its quaternized derivatives. These com-
pounds are molecules with high planarity which cannot
change their conﬁguration after quaternization.
The important parameters of a cyclic voltammetry (CV)
arethereduction(Epc)andoxidation(Epa)potential,thedif-
ference between reduction and oxidation potentials, (ΔEp),
and formal reduction potential (E◦ ) of the observed waves.
[Note: E mid= E
◦ ]( Table 2 and see Figure 3).
The potential diﬀerence in CVs between the reduc-
tion and oxidation correspond to the HOMO-LUMO en-
ergy gaps of the compound [16]. Just as chemical reac-
tionsoccurduringtheelectrontransferbetweenHOMOand
LUMO energy levels, photochemical reactions are also based
on similar phenomena of energy transfer. Before and after
the quaternization, the HOMO-LUMO energy gap of zinc
bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine was un-
changed. The shapes of CVs clearly showed that quater-
nized zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyra-
zines had increased electron responsibility.
2.3. Cancercellstudy
The uptake of DMS quaternized zinc bis(1,4-didecylbenzo)-
bis(2,3-pyrido) porphyrazines was done in IU-002 cells.
IU-002 cells were incubated at 37◦C. After incubation forKeiichi Sakamoto et al. 5
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Figure 4: Fluorescence image of IU-002 cells. (a) Control and (b) Incubated with DMS quaternized zinc bis(1,4-didecylbenzo)-bis(2,3-
pyrido)porphyrazine and irradiated with halogen light for 10 minutes.
3 hours, cellular quaternized zinc bis(1,4-didecylbenzo)-
bis(2,3-pyrido) porphyrazines was observed with a ﬂuores-
cence microscope.
A ﬂuorescent substance was noted when the uptake
of DMS quaternized zinc bis(1,4-didecylbenzo)-bis(2,3-
pyrido) porphyrazines in IU-002 cells was carried out.
Cell rupture can be detected. Intact cells selectively con-
centrated ﬂuorescence. After exposure to halogen light for
10 minutes showed damage and loss of ﬂuorescence al-
though ﬂuorescence in cells occurred in perinuclear area (see
Figure 4).
Concequently, the light exposed DMS quaternized zinc
bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazines in cells
produces cell disruption that can be detected as a decrease as
ﬂuorescence.
2.4. Conclusions
Zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazines
were synthesized from an equimolar mixture of 3,6-
didecylphthalonitrile and 2,3-pyridine carbonitrile in the
presence of basic catalyst.
Zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazi-
nes having two pyridine and two alkyl-substituted benzene
rings reacted with DMS, DES, and MCAA as quaternizing
agents.
When MCAA and DMS were employed as quater-
nizing agents, zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido)
porphyrazines were changed to their quaternized derivatives.
However, when DES was employed, we showed that sulfona-
tion but not quaternization was achieved.
Electrochmeical characterization of zinc bis(1,4-
didecylbenzo)-bis(2,3-pyrido) porphyrazines and its
quaternized derivatives were estimated by CV technique.
The shapes of CVs clearly showed that quaternized zinc
bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazines had
increased electron responsibility.
The uptake of DMS-quaternized zinc bis(1,4-didecyl-
benzo)-bis(2,3-pyrido) porphyrazines was done in IU-002
cells.
The light-exposed DMS quaternized zinc bis(1,4-did-
ecylbenzo)-bis(2,3-pyrido) porphyrazines in cells produces
cell disruption that can be detected as a decrease in ﬂuores-
cence.
3. EXPERIMENTAL
3.1. Equipment
IR spectra were recorded on a Shimadzu FT-IR 8100A spec-
trometer using potassium bromide (KBr) pellets. UV-Vis
spectra were measured on a Shimadzu UV-2400PC spec-
trometer; each sample was prepared at 5.0 × 10
−5 moldm−3
in pyridine, toluene, and water. Fluorescence spectra were
recorded in toluene, pyridine, and water using either a Hi-
tachi F-4500 ﬂuorescence spectrometer or a Jasco (Nihon
Bunko) FP-6600 spectroﬂuorometer. 1H-NMR spectra were
measured at 400MHz on a Bruker Avance 400S in benzene-
d6 (C6H6-d6)orchloroform-d(CHCl3-d)usingtetramethyl-
silane (TMS) as an internal standard. Elemental analyses
werecarriedoutusingaPerkin-Elmer2400CHNinstrument.
Samplesforelementalanalysiswerepuriﬁedbyrepeatedsub-
limation;theinstrumentwascalibratedwithcopperphthalo-
cyanine. CVs were recorded on a BAS CV-50W voltammet-
ric analyzer at room temperature in 1 × 10
−3 moldm−3 ace-
tonitrile solution containing a 0.01moldm−3 tetrabutylam-
monium perchlorate (TBAP). CVs were recorded by scan-
ning the potential at a rate of 50mV s−1. The working and
counter electrodes were platinum wires and the reference
electrode was a silver/silver chloride- (Ag/AgCl) saturated
sodium chloride electrode. The area of the working electrode
was 2.0 ×10
−2 cm2.
3.2. Materials
T L Cw a sp e r f o r m e du s i n gM e r c k6 0F 254 silica gel on alu-
minium sheets. Merck Silica gel 60, particle size 0.063–
0.200nm 7734 grade was used in chromatographic separa-
tions.6 Metal-Based Drugs
Reagents were purchased from Sigma-Aldrich Chemicals
(Miss, USA) and were used as received without further pu-
riﬁcation.
3,6-Didecylphthalonitrile was synthesized from thio-
phene via 2,5-Didecylthiophene and 2,5-Didecylthiophene-
1,1-dioxide, in accordance with our previous reports [9–12].
1HN M R( δ 400MHz, CHCl3-d/ ppm) 0.88 (t, 6H), 1.26
(m, 32H), 2.85 (t, 4H), 7.46 (s, 2H); IR(ν KBr/cm−1) 2960
(νC–H), 2240 (νC≡N), 1560 (νC=C), 1460 (νC–C), 1410 (νC–C),
1230 (δC–H), 730 (δC–H); Anal Calcd. for C28H4N2: C. 82.69:
H. 10.85: N.6.86. Found: C.82.26: H. 10.84: N. 6.84.
2,3-Pyridine dicarbonitrile was synthesized from
pyridine-2,3-dicarboxylic acid. Pyridine-2,3-dicarboxylic
acid (15g, 0.09mol) in 200cm3 of ethanol was reﬂuxed in
7.5cm3 of concentrated sulfonic acid for 48 hours. After
the solvent was removed and neutralized with 3M NaOH
solution, the organic layer was extracted with three times of
75cm3 of diethyl ether. The extract was dried on calcium
chloride and ﬁltered and the solvent evaporated. The residue
was distilled to aﬀord pyridine 2,3-dicarboxy ester. The ester
was dissolved in concentrated aqueous ammonia and the
solution was stirred for 48 hours to aﬀord a white-colored
precipitate. The precipitate was ﬁltered oﬀ and the corre-
sponding diamide was obtained as m.p. 179–181◦C. Thionyl
chloride (9.6g, 0.08mol) was added dropwise to the diamide
(6.6g, 0.04mmol) in 56g of DMF at −10◦C. This mixture
was allowed to warm to room temperature and was stirred
for 24 hours. The solvent was removed by evaporation and
water was added to make the thionyl chloride ineﬀective and
then ﬁltered. The product was puriﬁed by chromatography
over silica gel with benzene-petroleum ether 1 : 1 as eluent,
giving a colorless solid (1.97 g, 17%), m.p. 265◦C.
1HN M R( δ 400MHz, CHCl3-d/ppm) 7.26 (s, 1H), 7.75
(s, 1H), 9.09 (s, 1H); IR(ν KBr/cm−1) 3090 (νC–H), 2240
(νC–N), 1600 (νC–C), 1550 (νC–C), 1470 (νC–C), 1220 (δC–H),
750 (δC–H); Anal Calcd. for C7H3N3: C. 65.11: H. 2.34:
N.32.55. Found: C.65.12: H. 2.34: N. 32.56.
3.3. Zincbis(1,4-didecylbenzo)-bis(2,3-pyrido)
porphyrazine
3,6-Didecylphthalonitrile (0.12g, 0.29mmol) and 2,3-
dicyanopyridine (0.04g, 0.29mmol) (see Figure 1) were dis-
solved in pentanol (7cm3) and zinc chloride (0.05g) was
added; the ensuing mixture was heated for 4 hours in the
presence of DBU as catalyst. After cooling, the reaction mix-
ture was dissolved in toluene (50cm3) and ﬁltered; the sol-
vent was removed by evaporation. The product was puri-
ﬁed by TLC (eluent : toluene) yielding a blue solid (0.13g;
yield 80%). 1HN M R( δ 400MHz, C6H6-d6/ppm) 0.9 (m,
12H, CH3), 1.61–2.61 (m, 64H, CH2), 4.18–4.36 (m, 8H, α-
CH2),7.45(m,4H,arom),8.26(m,6H,Py);IR(νKBr/cm−1)
2960 (νC–H), 1600 (νC–C), 1500 (νC–C), 1420 (νC–C), 1200
(δC–H), 1100 (δC–H), 750 (δC–H); UV-Vis [λmax toluene/nm
(log εmax)] 665 (5.494); Anal Calcd. for C70H94N10Zn: C.
73.68: H. 8.30: N.12.28. Found: C.73.67: H. 8.30: N. 12.28.
3.4. Quaternizationofzincbis(1,4-didecylbenzo)-
bis(2,3-pyrido)porphyrazine
Zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido) porphyrazine
(0.17g, 0.15mmol) reacted with MCAA (0.57g, 6mmol),
DES (0.1g, 0.6mmol) and DMS (0.2g, 1.5mmol), respec-
tively, in N,N-dimetylformamide (DMF) 140◦Cf o r2h o u r s
(see Figures 2 and 3). The reaction mixture was dissolved
in acetone (20cm3), cooled to room temperature, and the
resulting solution was ﬁltered. The solvent was removed and
t h ep r o d u c tw a sp u r i ﬁ e db yT L C( e l u e n t:T H F - t o l u e n e ,
8 : 2); the product was recovered from the TLC plate via
dissolution in pyridine followed by ﬁltration and solvent
removal. MCAA:Yield 25%, 1HN M R( δ 400MHz, C6H6-d6/
ppm) 0.87(m, 12H, CH3), 1.13–1.70(m, 56H, γ-CH2), 1.82–
2.61(m, 8H, β-CH2), 4.11–4.38(m, 4H, α-CH2), 6.20(s, 2H,
CH2), 7.14–7.27(m, 4H, Arom), 8.73–.16(m, 6H, Py): IR(ν
KBr/cm−1) 3480(νO–H), 3050, 2970(νC–H), 1740(νC=O), 1600,
1500, 1400(νC=C), 1210, 1100, 940, 790, 690(δC–H); DES
yield 21%, (δ 400MHz, C6H6-d6/ppm) 0.86(m, 12H, CH3),
1.02–1.63(m, 56H, γ-CH2), 1.88–2.61(m, 8H, β-CH2),
4.26–4.50(m, 4H, α-CH2), 7.37(m, 4H, Arom), 8.22(m,
4H, Py): IR(ν KBr/cm−1) 3480(νO–H), 3050, 2960(νC–H),
1600, 1460, 1400(νC=C), 1350, 1150(νS=O), 1250, 920,
770(δC–H), 580(δC-S); DMS yield 25%, (δ 400MHz, C6H6-
d6/ppm) 0.90(m, 12H, CH3), 0.95–1.45(m, 56H, γ-CH2),
1.60–2.41(m, 8H, β-CH2), 4.05(s, 6H, CH3), 4.25–4.42(m,
4H, α-CH2), 7.45(m, 4H, Arom), 8.02(m, 6H, Py): IR(ν
KBr/cm−1) 3070, 2980(νC–H), 1500, 1400(νC=C), 1250, 1100,
950, 810, 660(δC–H).
3.5. Cellculture
IU-002 cells were maintained in MEM medium supple-
mented 5% fetal calf serum.
Cells seeded into 96-well tissue culture plates and in-
cubated to allow attachment to the plates. The sensitizer
was added to the medium at concentration ranging from
0to2mgcm3 . Cells were incubated for 3 hours. The medium
was removed, the cells were washed with phosphate-buﬀered
saline (PBS), and fresh medium was added. Cells were ex-
posed halogen light for 10 minutes. Appearance of cells was
observed used a ﬂuorescence microscope.
ACKNOWLEDGMENTS
The assistance of Miss T. Komoriya in the taking of data
for part of cell culture is greatly appreciated. The authors
would like to thank Professor Kohono for his helpful ad-
vice given to them regarding their paper. This research work
wassupported ﬁnancially by Advanced Research Center for
Life Science and Human Environment, Graduate School
of Industrial Technology, Nihon University (Narashino-shi,
Japan), which was adopted by a project for the promotion of
high technology within The Ministry of Education and Sci-
ence, Japan’s Academic Frontier Project.Keiichi Sakamoto et al. 7
REFERENCES
[1] N. B. McKeown, Phthalocyanine Materials—Synthesis Struc-
ture and Function, Cambridge University Press, Cambridge,
UK, 1998.
[2] C. C. Leznﬀ a n dA .B .P .L e v e r ,Phthalocyanines—Properties
and Applications, vol. 1–4, VCH, New York, NY, USA, 1989,
1993, 1996.
[3] R. Hirohashi, K. Sakamoto, and E. Ohno-Okumura, Phthalo-
cyanines as Functional Dyes, ICP, Tokyo, Japan, 2004.
[4] I.Okura,PhotosensitizationofPorphyrinsandPhthalocyanines,
Kodansya, Tokyo, Japan, 2000.
[5] G. Jory, “Photosensitised processes in vivo: Proposed pho-
totherapeutic applications,” Photochemistry and Photobiology,
vol. 52, pp. 439–443, 1990.
[6] J. Moan, “Properties for optimal PDT sensitizers,” Journal of
PhotochemistryandPhotobiology.B,Biology,v ol.5,no .3-4,pp .
521–524, 1990.
[7] M. J. Cook, I. Chambrier, S. J. Cracknell, D. A. Mayes, and D.
A. Russell, “Octa-alkyl zinc phthalocyanines: potential pho-
tosensitizers for use in the photodynamic therapy of cancer,”
Photochemistry and Photobiology, vol. 62, no. 3, pp. 542–545,
1995.
[8] K. Tabata, K. Fukushima, K. Oda, and I. Okura, “Selective ag-
gregation of zinc phthalocyanines in the skin,” Journal of Por-
phyrins and Phthalocyanines, vol. 4, no. 3, pp. 278–284, 2000.
[9] K. Sakamoto, T. Kato, and M. J. Cook, “Position isomer sep-
aration of non-peripheral substituted zinc dibenzo-di(3,4-
pyrido)porphyrazines,” Journal of Porphyrins and Phthalocya-
nines, vol. 5, no. 10, pp. 742–750, 2001.
[10] K. Sakamoto, T. Kato, T. Kawaguchi, et al., “Photosensitizer
eﬃcacy of non-peripheral substituted alkylbenzopyridopor-
phyrazines for photodynamic therapy of cancer,” Journal of
Photochemistryand Photobiology A:Chemistry,vol.153,no.1–
3, pp. 245–253, 2002.
[11] K. Sakamoto, E. Ohno-Okumura, T. Kato, T. Kawaguchi, and
M. J. Cook, “Laser-ﬂash photolysis of dialkylbenzodipyrido-
porphyrazines,” Journal of Porphyrins and Phthalocyanines,
vol. 7, no. 2, pp. 83–88, 2003.
[12] K. Sakamoto, T. Kato, E. Ohno-Okumura, M. Watanabe, and
M. J. Cook, “Synthesis of novel cationic amphiphilic phthalo-
cyanine derivatives for next generation photosensitizer using
photodynamic therapy of cancer,” Dyes and Pigments, vol. 64,
no. 1, pp. 63–71, 2005.
[13] I. Seotsanya-mokhosi, N. Kuznetsova, and J. T. Nyokong,
“Photochemical studies of tetra-2,3-pyridinoporphyrazines,”
Journal of Photochemistry and Photobiology A: Chemistry,
vol. 140, no. 3, pp. 215–222, 2001.
[14] M. Yokote, F. Shibamiya, and S. Shoji, “On the copper
phthalocyanine-N-isolog (copper tetra-3,4-pyridoporphyra-
zine) obtained from Cinchomeronic acid,” Kogyo Kagaku
Zasshi, vol. 67, pp. 166–176, 1964.
[15] K. Sakamoto and F. Shibamiya, “Reaction of copper diber-
zodipyridoporphyrazine with diethylsulfate,” Journal of the
Japan Society of Colour Material, vol. 59, pp. 517–524, 1986.
[16] K. Kadish, G. Moninot, Y. Hu, et al., “Double-decker actinide
porphyrins and phthalocyanines. Synthesis and spectroscopic
characterization of neutral, oxidized, and reduced homo- and
heteroleptic complexes,” Journal of AmericanChemical Society,
vol. 115, pp. 8153–8166, 1993.